Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3 results about "Bilirubin concentration" patented technology

Serum total bilirubin concentration was significantly lower in patients with retinopathy/nephropathy than in those without complications. Receiver operating characteristic analysis indicated that a bilirubin concentration of 0.55 mg/dl might be the appropriate threshold for the detection of retinopathy/nephropathy.

An extraction device for bilirubin concentration detection

This utility model relates to the field of bilirubin concentration detection technology, and mainly to an extraction device for bilirubin concentration detection. It includes an aspirator tube for serum aspiration, a storage frame, and an operating tube. Multiple aspirator tubes are inserted into the storage frame. The operating tube has a connector, and the connector and the storage frame have a docking part. The storage frame has a pushing part for moving multiple aspirator tubes into the operating tube, and a pushing component is located inside the operating tube. This utility model optimizes the traditional serum collection method for bilirubin concentration detection. By using a designed negative pressure adsorption component in conjunction with the aspirator tube, it achieves the absorption and storage of the upper serum layer. Compared with the traditional method of immediate transfer after aspirating with a pipette, personnel can extract all the serum in batches at once. During operation, it effectively avoids forgetting to replace the pipette or serum contamination caused by contact between the pipette and the outside environment.
Owner:SICHUAN FEIDELI PHARM CO LTD

A non-invasive device and associated method for measuring concentration of bilirubin

PCT designated stageWO2026139976A1EngineeringPhotodiode
A non-invasive device (10) includes contact tip member (12) configured to contact skin surface of body of person, optical beam concentrator (18) disposed at least partially within contact tip member (12), optical detection unit (14) coupled to contact tip member (12). The optical detection unit (14) includes optical housing (22), light source (20) disposed within optical housing (22) and configured to emit white light, plurality of optical members disposed within optical housing (22). It further includes optical sensor (32) having optical filter (34) and photodiode layer (36) disposed on optical filter (34), disposed within optical housing (22). The optical detection unit (14) further includes casing (16) coupled to optical detection unit. The device (10) further includes processing unit (48) configured to determine a value indicative of concentration of bilirubin based on output from optical sensor (32), using predetermined equation obtained from statistical based regression analysis technique.
Owner:MEDBLUE INNOVATIONS PVT LTD

Real-time non-invasive bilirubin monitoring system for newborns based on near-infrared spectroscopy

The present application provides a kind of newborn noninvasive bilirubin real-time monitoring system based on near infrared spectroscopy, comprising: monitoring bracelet, mobile terminal and / or hospital monitoring system, bracelet integrates multi-wavelength near infrared sensor and AI algorithm, noninvasive, continuously monitor the concentration change of bilirubin through wrist skin, and real-time wireless transmission to terminal, realize jaundice dynamic management.Using near infrared spectroscopy technology, without blood sampling, noninvasive monitoring, 24 hours continuous tracking of bilirubin concentration dynamic change, avoid the pain and infection risk of invasive operation, can be used as a substitute or supplementary means for serum detection.According to the day age of newborn, set personalized threshold according to weight, combined with concentration change rate dynamic early warning, early signs of pathological jaundice are found, early warning response time ≤1 minute, the incidence of kernicterus is reduced by 25%, effectively guarantee the life and health of newborn.
Owner:ZHEJIANG XIAOSHAN HOSPITAL